P. Ralph, CLINICAL AND PRECLINICAL STUDIES PRESENTED AT THE KEYSTONE SYMPOSIUM ON ARTHRITIS, RELATED DISEASES, AND CYTOKINES, Lymphokine and cytokine research, 12(4), 1993, pp. 261-263
Topics include treatment of multiple sclerosis (MS) with T cell recept
or (TCR) peptides, rheumatoid arthritis (RA) with IL-1ra, IL-2 toxin c
onjugate, or antibodies to TNF, to CD4, or to ICAM-1, sepsis and five
other diseases with IL-1ra, and treatment of experimental animal disea
ses with soluble receptors, IL-12, TGF-beta2, or small molecule antago
nists of cytokines.